The 60-second version of TruAlt Bioenergy Limited — what it does, how it earns, and who it competes with, before any of the numbers below.
| Metric | FY23 | FY24 | FY25 | FY26 | 3Y CAGR |
|---|---|---|---|---|---|
| Revenue | ₹1,160 Cr | ₹1,223 Cr | ₹1,826 Cr | ₹1,698 Cr | +13.5% |
| EBITDA | ₹153 Cr | ₹238 Cr | ₹366 Cr | ₹371 Cr | +34.2% |
| EBITDA Margin | 13.2% | 19.5% | 20.0% | 21.9% | — |
| PAT (Net Profit) | ₹49 Cr | ₹32 Cr | ₹147 Cr | ₹96 Cr | +25.1% |
| ROE | 20.4% | 12.0% | 19.1% | 6.3% | — |
| ROCE | 8.8% | 13.3% | 15.1% | 10.6% | — |
| Total Debt | ₹863 Cr | ₹1,367 Cr | ₹1,557 Cr | ₹1,652 Cr | +24.1% |
| Free Cash Flow | -₹437 Cr | -₹321 Cr | ₹82 Cr | -₹806 Cr | — |
| Company | P/E | ROE |
|---|---|---|
| RELIANCE INDUSTRIES LTD | 21.9x | 8.3% |
| OIL AND NATURAL GAS CORP. | 6.4x | 11.7% |
| BHARAT PETROLEUM CORP LT | 7.3x | 17.1% |
| INDIAN OIL CORP LTD | 5.3x | 15.4% |
A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 4 high-severity red flags sit above this conclusion and should be read first.